Efficacy of Peginterferon alfa-2a and Ribavirin Combination Therapy in Treatment-naive Estonian Patients with Chronic Hepatitis C

Central European Journal of Public Health ◽

10.21101/cejph.a3706 ◽

2012 ◽

Vol 20 (2) ◽

pp. 150-155 ◽

Author(s):

Vadim Brjalin ◽

Riina Salupere ◽

Tatjana Tallo ◽

Tatiana Kuznetsova ◽

Ljudmilla Priimägi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Treatment Naïve ◽

Peginterferon Alfa

Download Full-text

522 Combination therapy with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment-naive patients with chronic hepatitis C and genotype 1 infection: Individual estimated probability of sustained virological response (SVR)

Journal of Hepatology ◽

10.1016/s0168-8278(04)90522-3 ◽

2004 ◽

Vol 40 ◽

pp. 154 ◽

Author(s):

O. Weiland ◽

M.W. Fried ◽

S.J. Hadziyannis ◽

G.R. Foster ◽

D. Messinger ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Sustained Virological Response ◽

Chronic Hepatitis C ◽

Virological Response ◽

Treatment Naïve ◽

Peginterferon Alfa

Download Full-text

Peginterferon alfa-2b and ribavirin combination therapy for chronic hepatitis C

Future Virology ◽

10.2217/17460794.2.6.553 ◽

2007 ◽

Vol 2 (6) ◽

pp. 553-563

Author(s):

Frank Yeh ◽

Fredric D Gordon

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Peginterferon Alfa

Download Full-text

1163 A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

Journal of Hepatology ◽

10.1016/s0168-8278(12)61175-1 ◽

2012 ◽

Vol 56 ◽

pp. S460 ◽

Author(s):

H. Tatum ◽

P. Thuluvath ◽

E. Lawitz ◽

C.T. Martorell ◽

M. Demicco ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Hepatitis C Infection ◽

Ns5b Polymerase Inhibitor ◽

Treatment Naïve ◽

Polymerase Inhibitor ◽

Peginterferon Alfa ◽

Ns5b Polymerase

Download Full-text

PIN6 CLINICAL EFFECTIVENESS AND COST-EFFECTIVENESS OF ANTIVIRAL COMBINATION THERAPY WITH PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR CHRONIC HEPATITIS C ADMINISTERED ACCORDING TO THE NEW GENOTYPESPECIFIC GUIDELINES

Value in Health ◽

10.1016/s1098-3015(10)66023-8 ◽

2004 ◽

Vol 7 (6) ◽

pp. 759-760

Author(s):

U Siebert ◽

G Sroczynski ◽

P Aidelsburger ◽

S Rossol ◽

J Wasem ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Clinical Effectiveness ◽

Peginterferon Alfa

Download Full-text

Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

Annals of Internal Medicine ◽

10.7326/m15-0785 ◽

2015 ◽

Vol 163 (1) ◽

pp. 1 ◽

Author(s):

Stefan Zeuzem ◽

Reem Ghalib ◽

K. Rajender Reddy ◽

Paul J. Pockros ◽

Ziv Ben Ari ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Chronic Hepatitis C Virus ◽

Treatment Naïve

Download Full-text

996 Combination therapy of peginterferon alfa-2A (40KD) (PEGASYS(R)) and ribavirin (COPEGUS(R)) significantly enhance sustained virological and biochemical response rate in chronic hepatitis C genotype 4 patients in Saudi Arabia

10.1016/s0270-9139(03)81034-0 ◽

2003 ◽

Vol 38 ◽

pp. 636-636 ◽

Author(s):

O SHOBOKSHI ◽

F SEREBOUR ◽

L SKAKNI ◽

N ALJASSER ◽

A TANTAWI ◽

...

Keyword(s):

Saudi Arabia ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Response Rate ◽

Biochemical Response ◽

Peginterferon Alfa

Download Full-text

Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C

Journal of Hepatology ◽

10.1016/j.jhep.2009.01.017 ◽

2009 ◽

Vol 51 (1) ◽

pp. 21-28 ◽

Author(s):

Avidan U. Neumann ◽

Stephen Pianko ◽

Stefan Zeuzem ◽

Eric M. Yoshida ◽

Yves Benhamou ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Sustained Virologic Response ◽

Virologic Response ◽

Negative Prediction ◽

Treatment Naïve ◽

Peginterferon Alfa

Download Full-text

Effectiveness of peginterferon alfa-2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting

Digestive and Liver Disease ◽

10.1016/s1590-8658(06)80519-0 ◽

2006 ◽

Vol 38 ◽

pp. S192

Author(s):

N. Terreni ◽

G. Mandelli ◽

G. Spinzi ◽

G. Minoli

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Clinic Setting ◽

Peginterferon Alfa

Download Full-text

Extending combination therapy with peginterferon alfa-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: A report of 9 cases

10.1053/jhep.2003.50107 ◽

2003 ◽

Vol 37 (5) ◽

pp. 1226-1227 ◽

Author(s):

Maria Buti ◽

Auristela Valdes ◽

Francisco Sanchez-Avila ◽

Rafael Esteban ◽

Yoav Lurie

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Peginterferon Alfa

Download Full-text

P1126 IMPACT OF SAFETY-RELATED DOSE REDUCTIONS AND DISCONTINUATIONS (SR-RD) ON SUSTAINED VIROLOGICAL RESPONSE (SVR) IN TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS RECEIVING PEGINTERFERON ALFA-2a/RIBAVIRIN: RESULTS FROM GUARD-C

Journal of Hepatology ◽

10.1016/s0168-8278(14)61286-1 ◽

2014 ◽

Vol 60 (1) ◽

pp. S455

Author(s):

G.R. Foster ◽

C. Coppola ◽

M. Curescu ◽

M. Derbala ◽

G. Esmat ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Sustained Virological Response ◽

Chronic Hepatitis C ◽

Virological Response ◽

Treatment Naïve ◽

Peginterferon Alfa ◽

Chronic Hepatitis C Patients ◽

Dose Reductions

Download Full-text